News

Maryland-based MedImmune said it has begun dosing at-risk children six months to 24 months of age in a phase I trial of a vaccine designed to help prevent

Avanir said in light of the reduced operating infrastructure anticipated following the sale of FazaClo, Mike Puntoriero, senior vice president and CFO, will be resigning his position. Martin

The drug, EPC2407, belongs to a novel class of microtubulin inhibitors discovered by New York drug developer EpiCept. These compounds cause caspase activation, cell cycle arrest, and apoptotic

The National Institute for Health and Clinical Excellence (NICE) has approved the drug, despite concerns over its high cost and clinical effectiveness. The recommendation reverses an earlier decision

The study reports that for patients taking Tarceva who developed a moderate to severe rash, survival without progression of disease was 245% longer than in patients who had

The phase IIb cancer cachexia trial is a randomized, double blind, placebo controlled study of muscle wasting in 150 patients with non-small cell lung cancer, colorectal cancer, non-Hodgkin’s

The company says the 75mg capsules for treating adults and the liquid form of Tamiflu will continue to be available. The shelf life of the capsules is 5

The company reported results from preclinical research demonstrating that antibodies directed to a potential new target, angiopoietin-like protein 4 (ANGPTL4), rapidly lower triglycerides and cholesterol. Research suggests that

The FDA originally proposed its “black box warning” about anaphylaxis back in February. The label’s final wording has only recently been announced. Xolair, which is known generically as